Novugen focuses on complex generics and difficult to develop products in all therapeutic areas of general pharmaceutical and oncology products. Through our passionate teams, we aim to provide early access to the highest quality medicine with continuous investment in R&D.
Solid Oral dosage forms (Tablets, Capsules, Powders, Sachets, Pellets and Beads)
Parenteral dosage forms (Liquid and Lyophilized powders)
Complex generics (Modified Release, Bilayer, MUPS and OCAS)
Our portfolio consists of technology intensive products across a broad spectrum of disease areas.
Over 70 complex Finished Products
Active Pharmaceutical Ingredients (API) products under development and registration in various regions